Response to Thal treatment is accompanied by an increase in plasma IL-2 and IFN-γ levels and an increase in percentage of NK cells.

Paraprotein measurement (A), flow cytometry (B), and cytokine levels (C, D) were performed on patients receiving Thal therapy for relapsed MM at weekly intervals for 4 weeks.